DIAZABICYCLIC CENTRAL NERVOUS SYSTEM ACTIVE AGENTS

COMPOUNDS OF FORMULA I PHARMACEUTICAL COMPOSITIONS OF THESE COMPOUNDS, AND USE OF SAID COMPOSITIONS TO CONTROL SYNAPTIC TRANSMISSION IN MAMMALS.

Saved in:
Bibliographic Details
Main Authors JEROME F. DAANEN, WILLIAM H. BUNNELLE, JENNIFER MARY PACE, KEVIN B. SIPPY, RICHARD B. TOUPENCE, ANWER BASHA, JIANGUO JI, MICHAEL R. SCHRIMPF, KARIN R. TIETJE
Format Patent
LanguageEnglish
Published 30.03.2012
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:COMPOUNDS OF FORMULA I PHARMACEUTICAL COMPOSITIONS OF THESE COMPOUNDS, AND USE OF SAID COMPOSITIONS TO CONTROL SYNAPTIC TRANSMISSION IN MAMMALS.
Bibliography:Application Number: MY2005PI05633